Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Wang, Lihong ^a,b   Cao, Hailong ^b,c   Lu, Ning ^b,d   Liu, Liping ^b   Wang, Bangmao ^c   Hu, Tianhui ^a   Israel, Dawn A ^b   Peek, Richard M ^b,e   Polk, D Brent ^f   Yan, Fang ^b,d  

^a XIAMEN UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BERBERINE; CBL PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL STRAIN HT29; COLON TUMOR; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR XENOGRAFT; UBIQUITINATION;

EID: 84874005637     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056666     Document Type: Article

References (35)

1. Tillhon M, Guaman Ortiz LM, Lombardi P, Scovassi AI, (2012) Berberine: New perspectives for old remedies. Biochem Pharmacol 84: 1260-1267.
2. Gu L, Li N, Gong J, Li Q, Zhu W, et al. (2011) Berberine Ameliorates Intestinal Epithelial Tight-Junction Damage and Down-regulates Myosin Light Chain Kinase Pathways in a Mouse Model of Endotoxinemia. J Infect Dis 203: 1602-1612.
3. Tang J, Feng Y, Tsao S, Wang N, Curtain R, et al. (2009) Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17.
4. Sun Y, Xun K, Wang Y, Chen X, (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20: 757-769.
5. Yamaoka T, Yan F, Cao H, Hobbs SS, Dise RS, et al. (2008) Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci U S A 105: 11772-11777.
6. Olayioye MA, Neve RM, Lane HA, Hynes NE, (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167.
7. Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS, et al. (2003) Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor. Oncogene 22: 8509-8518.
8. de Melker AA, van der Horst G, Borst J, (2004) c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15. J Cell Sci 117: 5001-5012.
9. Mosesson Y, Shtiegman K, Katz M, Zwang Y, Vereb G, et al. (2003) Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation. J Biol Chem 278: 21323-21326.
10. Dikic I, Giordano S, (2003) Negative receptor signalling. Current Opinion in Cell Biology 15: 128-135.
11. Bucci M, Roviezzo F, Cicala C, Sessa WC, Cirino G, (2000) Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. Br J Pharmacol 131: 13-16.
12. de Renzis S, Sonnichsen B, Zerial M, (2002) Divalent Rab effectors regulate the sub-compartmental organization and sorting of early endosomes. Nat Cell Biol 4: 124-133.
13. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, et al. (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499.
14. Goel GA, Kandiel A, Achkar JP, Lashner B, (2011) Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications. Am J Gastroenterol 106: 719-730.
15. Cohen G, Mustafi R, Chumsangsri A, Little N, Nathanson J, et al. (2006) Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci. Cancer Res 66: 5656-5664.
16. Goldstein NS, Armin M, (2001) Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 92: 1331-1346.
17. Roberts RB, Min L, Washington MK, Olsen SJ, Settle SH, et al. (2002) Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci U S A 99: 1521-1526.
18. Alferez D, Wilkinson RW, Watkins J, Poulsom R, Mandir N, et al. (2008) Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) mice. Mol Cancer Ther 7: 590-598.
19. Wheeler DL, Dunn EF, Harari PM, (2010) Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7: 493-507.
20. Whitehead RH, Joseph JL, (1994) Derivation of conditionally immortalized cell lines containing the Min mutation from the normal colonic mucosa and other tissues of an "Immortomouse"/Min hybrid. Epithelial Cell Biol 3: 119-125.
21. Wang L, Liu L, Shi Y, Cao H, Chaturvedi R, et al. (2012) Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing Factor. PLoS One 7: e36418.
22. Raiborg C, Stenmark H, (2009) The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458: 445-452.
23. Mantena SK, Sharma SD, Katiyar SK, (2006) Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 27: 2018-2027.
24. Chidambara Murthy KN, Jayaprakasha GK, Patil BS, (2012) The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol 688: 14-21.
25. Liebermann DA, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, et al. (2011) Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog 16: 129-140.
26. Fayolle C, Pourchet J, Cohen A, Pedeux R, Puisieux A, et al. (2006) UVB-induced G2 arrest of human melanocytes involves Cdc2 sequestration by Gadd45a in nuclear speckles. Cell Cycle 5: 1859-1864.
27. Vairapandi M, Balliet AG, Hoffman B, Liebermann DA, (2002) GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol 192: 327-338.
28. Jauhiainen A, Thomsen C, Strombom L, Grundevik P, Andersson C, et al. (2012) Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153. PLoS One 7: e33208.
29. Hogel H, Rantanen K, Jokilehto T, Grenman R, Jaakkola PM, (2011) Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells. PLoS One 6: e27112.
30. Meyerhardt JA, Mayer RJ, (2005) Systemic therapy for colorectal cancer. N Engl J Med 352: 476-487.
31. Wang N, Feng Y, Zhu M, Tsang CM, Man K, et al. (2010) Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 111: 1426-1436.
32. Malynn BA, de Alboran IM, O'Hagan RC, Bronson R, Davidson L, et al. (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14: 1390-1399.
33. Zhang X, Gu L, Li J, Shah N, He J, et al. (2010) Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res 70: 9895-9904.
34. Budanov AV, Karin M, (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451-460.
35. Yan F, Cao H, Cover TL, Washington MK, Shi Y, et al. (2011) Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121: 2242-2253.